Search Results - "Gavish, D."

Does metformin treatment influence bone formation in patients with nonalcoholic fatty liver disease? by Soifer, E, Gavish, D, Shargorodsky, M

“…Antidiabetic drug metformin that improves insulin sensitivity and used in the treatment of nonalcoholic fatty liver disease (NAFLD), may affect the bone…”
Get more information

Effect of high doses of vitamin D on arterial properties, adiponectin and glucose homeostasis in type 2 diabetic patients by Shargorodsky, M, Gavish, D

Get full text

Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis by Shargorodsky, M, Boaz, M, Goldberg, Y, Matas, Z, Gavish, D, Fux, A, Wolfson, N

“…Objectives: Adiponectin is an adipocyte-derived collagen-like protein, highly specific to adipose tissue and may represent an important link between obesity…”
Get full text

Effect of angiotensin II receptor blockers, candesartan, on osteoprotegerin level in hypertensive patients: Link between bone and RAAS by Oz, H, Gavish, D, Hass, A, Shargorodsky, M

“…Introduction: The renin-angiotensin-aldosterone system (RAAS) has recently been considered as a possible link between bone and vascular disease. The present…”
Get full text

Osteoprotegerin as an independent marker of subclinical atherosclerosis in osteoporotic postmenopausal women by Shargorodsky, M, Boaz, M, Luckish, A, Matas, Z, Gavish, D, Mashavi, M

“…Abstract Osteoprotegerin (OPG) appears to represent the molecular link between bone resorption and vascular calcification, and may help to explain the high…”
Get full text

The effect of a rapid weight loss induced by laparoscopic adjustable gastric banding on arterial stiffness, metabolic and inflammatory parameters in patients with morbid obesity by SHARGORODSKY, M, FLEED, A, BOAZ, M, GAVISH, D, ZIMLICHMAN, R

“…To determine the effect of drastic weight loss on arterial compliance, inflammatory and metabolic parameters in patients with morbid obesity with and without…”
Get full text

Long-term thyrotropin-suppressive therapy with levothyroxine impairs small and large artery elasticity and increases left ventricular mass in patients with thyroid carcinoma by Shargorodsky, M, Serov, S, Gavish, D, Leibovitz, E, Harpaz, D, Zimlichman, R

“…Exogenous subclinical hyperthyroidism, caused by long-term thyrotropin (TSH)-suppressive treatment with levothyroxine (LT(4)), is associated with several…”
Get more information

High dose treatment with angiotensin II receptor blocker in patients with hypertension: Differential effect of tissue protection versus blood pressure lowering by Shargorodsky, M, Hass, E, Boaz, M, Gavish, D, Zimlichman, R

“…Abstract Aggressive inhibition of renin–angiotensin–aldosterone system may provide the best cardiovascular protection. We examined the effect of different…”
Get full text

Effect of homocysteine-lowering therapy on arterial elasticity and metabolic parameters in metformin-treated diabetic patients by Mashavi, M, Hanah, R, Boaz, M, Gavish, D, Matas, Z, Fux, A, Shargorodsky, M

“…Abstract Metformin may affect the risk of atherothrombotic disease. However, metformin increases levels of homocysteine (Hcy), considered an independent risk…”
Get full text

Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factors by Luckish, A, Cernes, R, Boaz, M, Gavish, D, Matas, Z, Fux, A, Shargorodsky, M

“…Abstract Accumulating evidence suggests that osteoporosis and coronary artery disease have epidemiologic similarities. Moreover, the anti-atherogenic effects…”
Get full text

Bezafibrate and simvastatin combination therapy for diabetic dyslipidaemia: efficacy and safety by Gavish, D., Leibovitz, E., Shapira, I., Rubinstein, A.

“… Gavish D, Leibovitz E, Shapira I, Rubinstein A (Wolfson Medical Center, Holon, and Tel Aviv Sourasky Medical Center, Tel Aviv, Israel). Bezafibrate and…”
Get full text

Effect of long-term treatment with rosiglitazone on arterial elasticity and metabolic parameters in patients with Type 2 diabetes mellitus: a 2-year follow-up study by Shargorodsky, M., Michaelova, K., Boaz, M., Gavish, D., Zimlichman, R.

“…Aims  Thiazolidinediones may influence the atherogenic process by improving cardiovascular risk factors. The present study was designed to determine the…”
Get full text

HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels by KOSTNER, G. M, GAVISH, D, LEOPOLD, B, BOLZANO, K, WEINTRAUB, M. S, BRESLOW, J. L

“…Lp(a) is a plasma lipoprotein particle consisting of a plasminogenlike protein [apo(a)] disulfide bonded to the apo B moiety of low-density lipoprotein (LDL)…”
Get full text

Is HDL-Cholesterol still a target for pharmacologic therapy? by Gavish, D.

Get full text

The Ashkelon Hypertension Detection and Control Program (AHDC Program): a community approach to reducing cardiovascular mortality by Yosefy, C, Dicker, D, Viskoper, J.R, Tulchinsky, T.H, Ginsberg, G.M, Leibovitz, E, Gavish, D

“…Blood pressure (BP) reduction is crucial in reducing cardiovascular (CV) morbidity and mortality in the community. Subjects aged 20–65 seldom visit the primary…”
Get full text

Plasma Lp(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the Apo(a) gene by GAVISH, D, AZROLAN, N, BRESLOW, J. L

“…Plasma Lp(a) levels correlate with atherosclerosis susceptibility. This lipoprotein consists of an LDL-like particle attached to a large glycoprotein called…”
Get full text

Plasma lipoprotein(a) concentration is controlled by apolipoprotein(a) (apo(a)) protein size and the abundance of hepatic apo(a) mRNA in a cynomolgus monkey model by AZROLAN, N, GAVISH, D, BRESLOW, J. L

“…The cynomolgus macaque was used as a model to study lipoprotein(a) (Lp(a)). Antibodies to Lp(a) were used in Ouchterlony and Western blot analysis to show that…”
Get full text

Lipoprotein(a) reduction by N-acetylcysteine by Gavish, D, Breslow, J L

“…Lipoprotein(a), a complex of low-density lipoprotein linked by disulphide bridges with apo(a), is associated with atherosclerotic disease when present at very…”
Get more information

Medical history of hypercholesterolaemia adversely affects the outcome of out-of-hospital cardiopulmonary resuscitation. The ‘Shahal’ experience in Israel by Roth, A, Golovner, M, Gavish, D, Shapira, I, Malov, N, Sender, J, Alroy, I, Kaplinski, E, Laniado, S

“…Aims To evaluate the impact selected risk factors for cardiac death may have on the success rate in a large cohort of subscribers to ‘SHAHAL’ who were…”
Get full text

Abnormalities in very low, low, and high density lipoproteins in hypertriglyceridemia: reversal toward normal with bezafibrate treatment by EISENBERG, S, GAVISH, D, OSCHRY, Y, FAINARU, M, DECKELBAUM, R. J

“…The effects of triglyceridemia on plasma lipoproteins were investigated in 16 hypertriglyceridemic (HTG) subjects (222-2,500 mg/dl) before and after the…”
Get full text